AIM:PXS · Consumer Staples · AIM-listed functional food / nutraceutical ingredient developer focused on cardiovascular health products

Provexis plc

Provexis plc is an AIM-listed (PXS) UK company that discovers, develops and commercialises functional food, medical food and dietary supplement technologies, centred on its patented Fruitflow heart-health ingredient (a natural anti-platelet extract from tomatoes). Fruitflow is sold as an ingredient to brand owners via former DSM customers, direct customers, and a long-term supply and distribution agreement with BYHEALTH Co., Ltd for the Chinese market; the group also sells a direct-to-consumer Fruitflow+ Omega-3 dietary supplement. The group has been loss-making since inception and is funded exclusively by equity capital.

Export the Provexis plc factsheetfree account Open the FY2026 report

Share price and financials

No price history · 12 reported years, FY2015–FY2026

No daily prices have been collected for this company.

Line	FY2015locked	FY2016locked	FY2017locked	FY2018locked	FY2019locked	FY2020locked	FY2021locked	FY2022locked	FY2023locked	FY202603/26
Revenue	1.6	0.65	1.1	1.5	0.84	1.2	0.63	1.1	1.4
Gross profit	0.40	0.38	0.64	0.59	0.46	0.46	0.38	0.30	0.36
Operating profit	(0.54)	(0.38)	(0.51)	(0.66)	(0.42)	(0.61)	(0.70)	(0.62)	(0.62)
Adjusted operating profit	(0.23)	(0.21)	(0.43)	(0.39)	(0.28)	(0.28)	(0.21)	(0.48)	(0.54)	—
Net finance cost	(0.00)	(0.00)	(0.00)	(0.00)	(0.00)	(0.00)	(0.00)	(0.00)	(0.00)
Profit before tax	(0.65)	(0.35)	(0.50)	(0.56)	(0.72)	(0.57)	(0.35)	(0.68)	(0.59)
Tax charge	(0.01)	(0.01)	(0.00)	(0.00)	(0.01)	(0.01)	(0.00)	(0.00)	(0.01)
Profit for the year	(0.72)	(0.48)	(0.34)	(0.57)	(0.45)	(0.72)	(0.53)	(0.41)	(0.34)
EBITDA	(0.76)	(0.73)	(0.61)	(0.64)	(0.49)	(0.37)	(0.64)	(0.42)	(0.32)
Basic EPS	(0.03p)	(0.02p)	(0.03p)	(0.03p)	(0.02p)	(0.02p)	(0.02p)	(0.02p)	(0.02p)
Diluted EPS	(0.01p)	(0.02p)	(0.03p)	(0.03p)	(0.02p)	(0.03p)	(0.03p)	(0.03p)	(0.03p)

GBP millions, negatives in brackets. Per-share lines in pence. later is what a following report restated the figure to; vs is a second reading that disagrees. The figure shown is the one the original filing printed, and both readings are kept. Click any figure: opens the report page it was read from, highlighted; shows how it was calculated.

2 figures

3 years, at a glance

GBP · %

Dashed: Operating margin, in % on its own scale — read its shape, not its height against the bars.

FY2026Revenue£1.3mOperating margin−40.5%